Annual EBIT
-$253.94 M
-$26.65 M-11.73%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual earnings before interest & taxes is -$253.94 million, with the most recent change of -$26.65 million (-11.73%) on December 31, 2023.
- During the last 3 years, ZNTL annual EBIT has fallen by -$135.15 million (-113.78%).
- ZNTL annual EBIT is now -967.74% below its all-time high of -$23.78 million, reached on December 31, 2018.
Performance
ZNTL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$51.43 M
+$13.72 M+21.05%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly earnings before interest & taxes is -$51.43 million, with the most recent change of +$13.72 million (+21.05%) on September 30, 2024.
- Over the past year, ZNTL quarterly EBIT has increased by +$11.29 million (+17.99%).
- ZNTL quarterly EBIT is now -489.68% below its all-time high of -$8.72 million, reached on March 31, 2019.
Performance
ZNTL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$209.27 M
+$11.29 M+5.12%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL TTM earnings before interest & taxes is -$209.27 million, with the most recent change of +$11.29 million (+5.12%) on September 30, 2024.
- Over the past year, ZNTL TTM EBIT has increased by +$28.51 million (+11.99%).
- ZNTL TTM EBIT is now -2299.30% below its all-time high of -$8.72 million, reached on March 31, 2019.
Performance
ZNTL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ZNTL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.7% | +18.0% | +12.0% |
| 3 y3 years | -113.8% | +18.0% | +12.0% |
| 5 y5 years | -967.7% | +18.0% | +12.0% |
ZNTL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.3% | at low | -107.7% | +24.3% | at high | +17.6% |
| 5 y | 5-year | -442.1% | at low | -245.1% | +24.3% | -346.7% | +17.6% |
| alltime | all time | -967.7% | at low | -489.7% | +24.3% | -2299.3% | +17.6% |
Zentalis Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$51.43 M(-21.1%) | -$209.27 M(-5.1%) |
| Jun 2024 | - | -$65.15 M(+163.1%) | -$220.55 M(+3.2%) |
| Mar 2024 | - | -$24.77 M(-63.5%) | -$213.75 M(-15.8%) |
| Dec 2023 | -$253.94 M(+11.7%) | -$67.92 M(+8.3%) | -$253.94 M(+6.8%) |
| Sep 2023 | - | -$62.72 M(+7.5%) | -$237.77 M(+3.7%) |
| Jun 2023 | - | -$58.35 M(-10.2%) | -$229.25 M(-2.2%) |
| Mar 2023 | - | -$64.95 M(+25.5%) | -$234.36 M(+3.1%) |
| Dec 2022 | -$227.29 M(+5.0%) | -$51.75 M(-4.5%) | -$227.29 M(+1.6%) |
| Sep 2022 | - | -$54.19 M(-14.6%) | -$223.73 M(-3.7%) |
| Jun 2022 | - | -$63.46 M(+9.6%) | -$232.40 M(+3.7%) |
| Mar 2022 | - | -$57.88 M(+20.1%) | -$224.07 M(+3.5%) |
| Dec 2021 | -$216.54 M | -$48.19 M(-23.3%) | -$216.54 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$62.87 M(+14.0%) | -$208.59 M(+15.6%) |
| Jun 2021 | - | -$55.13 M(+9.5%) | -$180.49 M(+18.2%) |
| Mar 2021 | - | -$50.35 M(+25.1%) | -$152.74 M(+28.6%) |
| Dec 2020 | -$118.79 M(+153.6%) | -$40.24 M(+15.8%) | -$118.79 M(+27.1%) |
| Sep 2020 | - | -$34.77 M(+27.0%) | -$93.45 M(+31.1%) |
| Jun 2020 | - | -$27.38 M(+66.9%) | -$71.26 M(+30.7%) |
| Mar 2020 | - | -$16.40 M(+10.0%) | -$54.52 M(+16.4%) |
| Dec 2019 | -$46.84 M(+97.0%) | -$14.90 M(+18.5%) | -$46.84 M(+46.7%) |
| Sep 2019 | - | -$12.58 M(+18.3%) | -$31.94 M(+65.0%) |
| Jun 2019 | - | -$10.63 M(+21.9%) | -$19.36 M(+121.9%) |
| Mar 2019 | - | -$8.72 M | -$8.72 M |
| Dec 2018 | -$23.78 M | - | - |
FAQ
- What is Zentalis Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual EBIT year-on-year change?
- What is Zentalis Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly EBIT year-on-year change?
- What is Zentalis Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals TTM EBIT year-on-year change?
What is Zentalis Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ZNTL is -$253.94 M
What is the all time high annual EBIT for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual earnings before interest & taxes is -$23.78 M
What is Zentalis Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ZNTL annual earnings before interest & taxes has changed by -$26.65 M (-11.73%)
What is Zentalis Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ZNTL is -$51.43 M
What is the all time high quarterly EBIT for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$8.72 M
What is Zentalis Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ZNTL quarterly earnings before interest & taxes has changed by +$11.29 M (+17.99%)
What is Zentalis Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ZNTL is -$209.27 M
What is the all time high TTM EBIT for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high TTM earnings before interest & taxes is -$8.72 M
What is Zentalis Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ZNTL TTM earnings before interest & taxes has changed by +$28.51 M (+11.99%)